Objective The effect of intermittent iron supplementation weekly and twice weekly was studied in children with iron deficiency anemia(IDA). Methods Subjects were 58 children who were randomly divided into two groups. ...Objective The effect of intermittent iron supplementation weekly and twice weekly was studied in children with iron deficiency anemia(IDA). Methods Subjects were 58 children who were randomly divided into two groups. One group received a dosage of 2mg/kg Fe every 3d for 9 weeks. The other group received the same dose Fe once a week for 12 weeks. Results Hemoglobin and serum ferrltin increased significantly after treatment in both groups (P <o.o5), and zinc protoporphyrin decreased significantly (P <o. o5). But serum rerrltin of both groups was different after 6 weeks of treatment (P<o. o1). The side effect of the group supplemented once every 3d was higher than that of the group once a week, but there was no statistically significant difference. Conclusion Iron supplementation every 3d has a similar effect to once a week for treatment of IDA. The former should be used for the serious patients for 6 weeks. The later should be used for infants and the patients whose resistance of intestines and stomach are not good.展开更多
A total of 65 children with mild iron deficiency anemia (IDA) were divided into 5 groups, and received 0, 25, 50, 100 and 150 mg/day of vitamin C (VC) respectively every day for 8 weeks. Hemoglobin, serum ferritin, fr...A total of 65 children with mild iron deficiency anemia (IDA) were divided into 5 groups, and received 0, 25, 50, 100 and 150 mg/day of vitamin C (VC) respectively every day for 8 weeks. Hemoglobin, serum ferritin, free erythrocyte and hematocrit were determined every week. At a daily average intake of about 30 mg of VC and 7.5 mg of Fe, the results of the study indicate that: (1) VC supplement alone could effectively control children's IDA, and a dose-dependant relationship was observed. (2) 50 mg/day of VC is the most efficient dosage and 6 weeks is the shortest time for an effective therapy. (3) With a diet predominately comprised of plant foods, it is suggested that appropriate dose of VC should be supplemented for the children during winter and spring in northeastern areas of China.展开更多
Objective To assess the effectiveness of complementary food supplements with protein and multi-micronutrients on hemoglobin and anemia in infants and young children. Methods In 5 poor counties of Gansu, 984 children a...Objective To assess the effectiveness of complementary food supplements with protein and multi-micronutrients on hemoglobin and anemia in infants and young children. Methods In 5 poor counties of Gansu, 984 children aged 6-12 months were enrolled and divided into two groups. In addition to the usual home-made complementary food, all the children were fed one sachet of either Formula Ⅰ or Formula Ⅱ supplements each day. Protein and micronutrients were provided in Formula Ⅰ, while the same energy intake was secured in Formula Ⅱ as in Formula Ⅰ. A massive dose of vitamin A was supplemented to all the children every 6 months. Hemoglobin test was done at the same time. Results Prevalence of anemia was about 35% in both Formula Ⅰ and Formula Ⅱ group at baseline, and there were no differences in hemoglobin concentration between the two groups, During the 6-month and 12-month supplementation, hemoglobin of children in Formula Ⅰ group was higher than that in Formula Ⅱ group （P〈0.05）, and hemoglobin increase in Formula Ⅰ group was significantly higher than that in Formula Ⅱ group （P〈0.001）. After 6- and 12-mouth supplementation, the prevalence of anemia in Formula Ⅰ group dropped to 19.1% and 8.2% respectively, and it was 28.0% and 12.4% in Formula 2 group. The prevalence of anemia in Formula Ⅰ group was significantly lower than that in Formula Ⅱ group （P〈0.05）. After adjusting age and hemoglobin level at baseline, the hemoglobin increase at age of 24 months in formula 1 group was higher （10.7 g/L vs 7.9 g/L, P〈0.0001）. Conclusion Micronutrient fortified complementary food supplements, with large-dose vitamin A, is effective for children aged 6-12 months in terms of iron deficiency prevention.展开更多
目的:系统评价健脾生血颗粒单用或联合补铁制剂对比单用补铁制剂治疗儿童缺铁性贫血的疗效和安全性,为临床治疗儿童缺铁性贫血提供循证参考。方法:计算机检索PubMed、Embase、Medline、Scifinder、Cochrane图书馆、中国期刊全文数据库...目的:系统评价健脾生血颗粒单用或联合补铁制剂对比单用补铁制剂治疗儿童缺铁性贫血的疗效和安全性,为临床治疗儿童缺铁性贫血提供循证参考。方法:计算机检索PubMed、Embase、Medline、Scifinder、Cochrane图书馆、中国期刊全文数据库、维普网、万方数据,检索时限均为自建库起至2018年11月,收集健脾生血颗粒单用或联合补铁制剂(试验组)对比单用补铁制剂(对照组)治疗儿童缺铁性贫血疗效和安全性的随机对照试验(RCT),对符合纳入标准的临床研究进行资料提取,并用Cochrane系统评价员手册5.1.0进行质量评价后,采用Rev Man 5.3统计软件对总有效率、痊愈率、血红蛋白(HB)、平均红细胞体积(MCV)、红细胞平均血红蛋白量(MCH)、血清铁(SI)、血清铁蛋白(SF)升高水平和不良反应发生率进行Meta分析。结果:共纳入19项RCT,合计2 259例患者。Meta分析结果显示,试验组患者总有效率[OR=6.73,95%CI(4.68,9.68),P<0.001]、痊愈率[OR=2.51,95%CI(2.06,3.06),P<0.001]、HB升高水平[MD=8.91,95%CI(6.13,11.68),P<0.001]、MCV升高水平[MD=9.13,95%CI(5.32,12.95),P<0.001]、MCH升高水平[MD=2.95,95%CI(1.75,4.15),P<0.001]、SI升高水平[MD=3.66,95%CI(2.77,4.55),P<0.001]、SF升高水平[MD=10.82,95%CI(9.18,12.45),P<0.001]、不良反应发生率[OR=0.49,95%CI(0.33,0.71),P=0.000 2]均优于对照组,差异均有统计学意义。结论:健脾生血颗粒单用或联合补铁制剂对比单用补铁制剂在治疗儿童缺铁性贫血时,可提高患者总有效率、痊愈率和HB、MCV、MCH、SI、SF水平,降低不良反应发生率。展开更多
目的回顾性分析营养性缺铁性贫血(nutritional iron deficiency anemia,IDA)患儿的病例资料,考察其发病率与发病的相关因素,探讨对IDA患儿进行健康管理干预和治疗的临床效果。方法回顾性分析绍兴市人民医院2014年1月—2016年12月接诊的...目的回顾性分析营养性缺铁性贫血(nutritional iron deficiency anemia,IDA)患儿的病例资料,考察其发病率与发病的相关因素,探讨对IDA患儿进行健康管理干预和治疗的临床效果。方法回顾性分析绍兴市人民医院2014年1月—2016年12月接诊的疑似IDA患儿的病历资料,对其中5例确诊为IDA患儿均施行系统的持续性健康管理干预,必要的补铁治疗。考察小儿营养性缺铁性贫血(nutritional iron deficiency anemia of children,IDAC)的发病率;采用单因素分析考察IDA患儿发病的相关因素;比较经健康管理干预和治疗前、后患儿临床症状、体征及体重的变化,实验室相关指标血红蛋白(HGB)、血铁。结果 (1)51例(占14.57%,51/350)患儿确诊为IDA,其实验室检查外周血中的血红蛋白、血铁蛋白(Fer)含量均低于非IDA患儿差异有统计学意义(P<0.05)。1~3岁(含)幼儿的发病率最高。(2)经单因素分析发现,年龄、主要喂养方式、合并消化系统等疾病均为引起IDAC的相关因素。(3)经健康管理干预和治疗后,多数IDA患儿实验室指标中的血红蛋白、血铁蛋白及患儿体重均基本恢复至本院实验室正常参考值范围内。多数(96.08%,49例)患儿贫血及临床不适症状或异常体征得到有效的改善。结论 IDAC以1~3岁(含)幼儿多发,患病原因主要为膳食结构不合理、合并消化系统疾病等。对IDA患儿施行合理、持续的健康管理干预和治疗多可获得较为满意的临床效果。展开更多
文摘Objective The effect of intermittent iron supplementation weekly and twice weekly was studied in children with iron deficiency anemia(IDA). Methods Subjects were 58 children who were randomly divided into two groups. One group received a dosage of 2mg/kg Fe every 3d for 9 weeks. The other group received the same dose Fe once a week for 12 weeks. Results Hemoglobin and serum ferrltin increased significantly after treatment in both groups (P <o.o5), and zinc protoporphyrin decreased significantly (P <o. o5). But serum rerrltin of both groups was different after 6 weeks of treatment (P<o. o1). The side effect of the group supplemented once every 3d was higher than that of the group once a week, but there was no statistically significant difference. Conclusion Iron supplementation every 3d has a similar effect to once a week for treatment of IDA. The former should be used for the serious patients for 6 weeks. The later should be used for infants and the patients whose resistance of intestines and stomach are not good.
文摘A total of 65 children with mild iron deficiency anemia (IDA) were divided into 5 groups, and received 0, 25, 50, 100 and 150 mg/day of vitamin C (VC) respectively every day for 8 weeks. Hemoglobin, serum ferritin, free erythrocyte and hematocrit were determined every week. At a daily average intake of about 30 mg of VC and 7.5 mg of Fe, the results of the study indicate that: (1) VC supplement alone could effectively control children's IDA, and a dose-dependant relationship was observed. (2) 50 mg/day of VC is the most efficient dosage and 6 weeks is the shortest time for an effective therapy. (3) With a diet predominately comprised of plant foods, it is suggested that appropriate dose of VC should be supplemented for the children during winter and spring in northeastern areas of China.
文摘Objective To assess the effectiveness of complementary food supplements with protein and multi-micronutrients on hemoglobin and anemia in infants and young children. Methods In 5 poor counties of Gansu, 984 children aged 6-12 months were enrolled and divided into two groups. In addition to the usual home-made complementary food, all the children were fed one sachet of either Formula Ⅰ or Formula Ⅱ supplements each day. Protein and micronutrients were provided in Formula Ⅰ, while the same energy intake was secured in Formula Ⅱ as in Formula Ⅰ. A massive dose of vitamin A was supplemented to all the children every 6 months. Hemoglobin test was done at the same time. Results Prevalence of anemia was about 35% in both Formula Ⅰ and Formula Ⅱ group at baseline, and there were no differences in hemoglobin concentration between the two groups, During the 6-month and 12-month supplementation, hemoglobin of children in Formula Ⅰ group was higher than that in Formula Ⅱ group （P〈0.05）, and hemoglobin increase in Formula Ⅰ group was significantly higher than that in Formula Ⅱ group （P〈0.001）. After 6- and 12-mouth supplementation, the prevalence of anemia in Formula Ⅰ group dropped to 19.1% and 8.2% respectively, and it was 28.0% and 12.4% in Formula 2 group. The prevalence of anemia in Formula Ⅰ group was significantly lower than that in Formula Ⅱ group （P〈0.05）. After adjusting age and hemoglobin level at baseline, the hemoglobin increase at age of 24 months in formula 1 group was higher （10.7 g/L vs 7.9 g/L, P〈0.0001）. Conclusion Micronutrient fortified complementary food supplements, with large-dose vitamin A, is effective for children aged 6-12 months in terms of iron deficiency prevention.
文摘目的:系统评价健脾生血颗粒单用或联合补铁制剂对比单用补铁制剂治疗儿童缺铁性贫血的疗效和安全性,为临床治疗儿童缺铁性贫血提供循证参考。方法:计算机检索PubMed、Embase、Medline、Scifinder、Cochrane图书馆、中国期刊全文数据库、维普网、万方数据,检索时限均为自建库起至2018年11月,收集健脾生血颗粒单用或联合补铁制剂(试验组)对比单用补铁制剂(对照组)治疗儿童缺铁性贫血疗效和安全性的随机对照试验(RCT),对符合纳入标准的临床研究进行资料提取,并用Cochrane系统评价员手册5.1.0进行质量评价后,采用Rev Man 5.3统计软件对总有效率、痊愈率、血红蛋白(HB)、平均红细胞体积(MCV)、红细胞平均血红蛋白量(MCH)、血清铁(SI)、血清铁蛋白(SF)升高水平和不良反应发生率进行Meta分析。结果:共纳入19项RCT,合计2 259例患者。Meta分析结果显示,试验组患者总有效率[OR=6.73,95%CI(4.68,9.68),P<0.001]、痊愈率[OR=2.51,95%CI(2.06,3.06),P<0.001]、HB升高水平[MD=8.91,95%CI(6.13,11.68),P<0.001]、MCV升高水平[MD=9.13,95%CI(5.32,12.95),P<0.001]、MCH升高水平[MD=2.95,95%CI(1.75,4.15),P<0.001]、SI升高水平[MD=3.66,95%CI(2.77,4.55),P<0.001]、SF升高水平[MD=10.82,95%CI(9.18,12.45),P<0.001]、不良反应发生率[OR=0.49,95%CI(0.33,0.71),P=0.000 2]均优于对照组,差异均有统计学意义。结论:健脾生血颗粒单用或联合补铁制剂对比单用补铁制剂在治疗儿童缺铁性贫血时,可提高患者总有效率、痊愈率和HB、MCV、MCH、SI、SF水平,降低不良反应发生率。
文摘目的回顾性分析营养性缺铁性贫血(nutritional iron deficiency anemia,IDA)患儿的病例资料,考察其发病率与发病的相关因素,探讨对IDA患儿进行健康管理干预和治疗的临床效果。方法回顾性分析绍兴市人民医院2014年1月—2016年12月接诊的疑似IDA患儿的病历资料,对其中5例确诊为IDA患儿均施行系统的持续性健康管理干预,必要的补铁治疗。考察小儿营养性缺铁性贫血(nutritional iron deficiency anemia of children,IDAC)的发病率;采用单因素分析考察IDA患儿发病的相关因素;比较经健康管理干预和治疗前、后患儿临床症状、体征及体重的变化,实验室相关指标血红蛋白(HGB)、血铁。结果 (1)51例(占14.57%,51/350)患儿确诊为IDA,其实验室检查外周血中的血红蛋白、血铁蛋白(Fer)含量均低于非IDA患儿差异有统计学意义(P<0.05)。1~3岁(含)幼儿的发病率最高。(2)经单因素分析发现,年龄、主要喂养方式、合并消化系统等疾病均为引起IDAC的相关因素。(3)经健康管理干预和治疗后,多数IDA患儿实验室指标中的血红蛋白、血铁蛋白及患儿体重均基本恢复至本院实验室正常参考值范围内。多数(96.08%,49例)患儿贫血及临床不适症状或异常体征得到有效的改善。结论 IDAC以1~3岁(含)幼儿多发,患病原因主要为膳食结构不合理、合并消化系统疾病等。对IDA患儿施行合理、持续的健康管理干预和治疗多可获得较为满意的临床效果。
